Key result
The MB isoenzyme of creatine phosphokinase provides a specific plasma assay for diagnosing myocardial infarction and measuring the extent of myocardial damage.
Answers are grounded in this paper and cite their sources.
The MB isoenzyme of creatine phosphokinase provides a specific biomarker for diagnosing and quantifying myocardial infarction, overcoming the lack of specificity of previous enzymatic criteria.
Enzymatic criteria for diagnosis of myocardial infarction have suffered from a lack of specificity, since enzyme elevations also occur in noncardiac disorders. The MB isoenzyme of creatine phosphokinase has provided a way out of this difficulty. Not only is it specific to injured myocardium but a recently developed plasma assay makes possible both diagnosis and, in many cases, measurement of the extent of damage.
No takes yet. Share an insight, caveat, or question.
Roberts et al. (1976) conducted a review in Myocardial infarction. MB isoenzyme of creatine phosphokinase (CPK-MB) assay was evaluated. The MB isoenzyme of creatine phosphokinase provides a specific plasma assay for diagnosing myocardial infarction and measuring the extent of myocardial damage.
Synapse has enriched 10 related papers. Consider them for comparative context: